Clinical trials
Cirrhosis clinical trials
Below are recruiting cirrhosis clinical trials, each written for real people, not researchers. We’re tracking 261 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06812390RecruitingPhase 2
Albumin plus diuretics for cirrhosis-related leg swelling
This study tests whether giving albumin (a protein) along with water pills helps reduce leg swelling in people with cirrhosis and ascites. It may be an option if your leg swelling hasn't improved with standard diuretics alone.
West Haven, ConnecticutAges 18 years+ - NCT07322237RecruitingPhase 4
Study on heart function drugs for liver cirrhosis patients
This trial tests two heart medications, carvedilol and empagliflozin, to see if they improve heart function in people with cirrhosis (liver scarring). It might help those who have early signs of heart stiffness but normal pumping strength.
ChandigarhAges 18–65 - NCT07299110Recruiting
Whey vs. egg protein for ammonia levels in liver cirrhosis
This trial compares how whey protein and egg white protein affect ammonia levels in people with cirrhosis caused by alcohol. The goal is to see which protein source is safer for your liver.
New DelhiAges 18–70 - NCT07286643Recruiting
Ultrasound-guided sepsis care for patients with cirrhosis
This study tests whether using a special ultrasound of the heart can guide treatment for sepsis-related low blood pressure in patients with cirrhosis. It aims to improve care and outcomes for critically ill patients.
ChandigarhAges 18–65 - NCT07281846Recruiting
TIPS with or without BCAA for cirrhosis and muscle wasting
This trial tests whether adding branched-chain amino acids (BCAA) to the standard TIPS procedure helps people with cirrhosis and muscle wasting. It aims to see if BCAA can improve outcomes after TIPS.
WuhanAges 18–80 - NCT07271576Recruiting
Phycocyanin study for liver fibrosis and cirrhosis
This trial tests if phycocyanin (a natural blue pigment from spirulina) can help protect the liver and slow damage from fibrosis or cirrhosis. It may be an option if you have stable liver disease and are looking for supportive therapy.
HangzhouAges 18–75 - NCT07273331Enrolling by invitation
Nursing needs for people with cirrhosis
This study asks people with liver cirrhosis about their nursing needs. Your answers will help nurses better support others with the same condition.
ReykjavikAges Any age - NCT07253389Recruiting
Comparing two TIPS techniques to prevent variceal rebleeding in cirrhosis
This trial tests a slightly smaller TIPS stent (underdilated) against the standard size to see which is better at preventing another variceal bleed in people with cirrhosis and liver scarring. It aims to find the safest way to lower pressure in the veins while reducing side effects.
Xi'an, ShaanxiAges 18–75 - NCT06908785Recruiting
Blood test to predict bleeding risk after procedures in cirrhosis
This trial is testing if a special blood test called ROTEM can help doctors predict the risk of bleeding after high-risk procedures in people with cirrhosis. It aims to improve safety and guide treatment decisions.
Santander, CantabriaAges 18–65 - NCT06808074RecruitingPhase 4
Inhaled amikacin to prevent pneumonia in cirrhosis patients on ventilators
This trial tests whether inhaling an antibiotic called amikacin can prevent ventilator-associated pneumonia in patients with severe liver disease (cirrhosis) who are on a breathing machine. If you or your loved one is in the ICU with liver issues and needs a ventilator, this study may help reduce the risk of a serious lung infection.
Hyderabad, TelanganaAges 18 years+ - NCT04448028RecruitingPhase 4
Stopping acid pills in liver cirrhosis: test placebo effect
This study tests whether stopping proton-pump inhibitor (PPI) acid-reducing medication is safe and works as expected for people with liver cirrhosis. Participants switch to either the study medication or a placebo (inactive pill) under close monitoring.
Hamburg, Free and Hanseatic City of HamburgAges 18 years+ - NCT05201404RecruitingPhase 3
Namodenoson for advanced liver cancer with moderate cirrhosis
This Phase 3 trial studies whether namodenoson can slow or control advanced hepatocellular carcinoma (liver cancer) in people whose cirrhosis is in a specific middle range. It may help if standard treatments have not worked or the cancer has spread and is not expected to be cured.
Dallas, TexasAges 18 years+ - NCT07169526Recruiting
Health literacy and confidence in alcohol-related liver cirrhosis
This study looks at how well patients with alcohol-related liver cirrhosis understand health information and feel confident managing their health. It aims to find ways to support patients better.
HanoverAges 18–99 - NCT07172035Recruiting
TIPS and liver recovery in decompensated cirrhosis
This trial studies whether a procedure called TIPS (a stent placed in the liver to improve blood flow) can help people with advanced liver disease regain better liver function. It is for patients who have had complications like severe bleeding from the stomach or difficult-to-control fluid buildup (ascites).
ChangshaAges 18–80 - NCT07151885Recruiting
Using ultrasound and blood tests to predict varices risk in cirrhosis
This trial tests if a special ultrasound technique combined with liver stiffness and platelet count can predict which patients with cirrhosis have high-risk varices in the esophagus or stomach, potentially reducing the need for repeated endoscopy.
Changchun, JilinAges 18 years+ - NCT07147335Recruiting
Blood test for early liver cancer warning in cirrhosis
This study looks at whether a blood test for a protein called AKR1B10 can help give early warning of liver cancer (hepatocellular carcinoma) in people with cirrhosis. If you have cirrhosis or chronic hepatitis and are between 18 and 75 years old, you may be able to join.
Hengyang, HunanAges 18–75 - NCT07132515RecruitingPhase 4
Blood thinners for cirrhosis with portal vein clot
This study tests whether blood thinners (anticoagulants) are safe and effective for people with cirrhosis and a blood clot in the portal vein. It may also include people with liver cancer (HCC).
Al Mansurah, Dakahlia GovernorateAges 18–70 - NCT07116096Recruiting
Handgrip strength and blood flow in liver cirrhosis
This study measures how handgrip strength relates to blood flow in the portal vein (the main vein to the liver) in people with liver cirrhosis. It aims to find simple ways to check liver health.
Luoyang, HenanAges 18 years+ - NCT07108075Recruiting
Testing metformin and carvedilol for cirrhosis with variceal bleeding
This trial tests whether adding metformin to carvedilol (a standard drug) lowers liver pressure more than carvedilol alone in people with cirrhosis who have had variceal bleeding. The goal is to prevent future bleeding.
New Delhi, National Capital Territory of DelhiAges 18–75 - NCT05338294Recruiting
Tested surgery to help immune function in cirrhosis
This study looks at whether a type of keyhole spleen surgery plus cutting a large vein can improve immune function in people with cirrhosis. It may help reduce immune problems that can happen after complications like bleeding from varices (enlarged veins in the esophagus/stomach).
Yangzhou, JiangsuAges 18 years+ - NCT07046429Recruiting
Melatonin for sleep and brain health in cirrhosis
This study tests whether melatonin (a natural sleep hormone) can improve sleep and thinking abilities in people with cirrhosis and liver-related brain fog. It aims to see if better sleep leads to clearer thinking.
New York, New YorkAges 18 years+ - NCT07031843Recruiting
New prediction model study for liver cirrhosis
This study is exploring a new way to predict how liver cirrhosis will progress. It may help doctors better understand and manage the condition.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT07028580Recruiting
High-Protein Plant Diet for Liver Cirrhosis
This study tests whether a special diet high in plant-based protein (with some animal protein) can help people with severe liver cirrhosis who are waiting for a kidney transplant. The diet aims to improve nutrition and health without overloading the liver.
Athens, AtticaAges 18–80 - NCT07029243Recruiting
Prehabilitation and supplement for frail cirrhosis patients
This study tests whether a prehabilitation program (exercise and nutrition planning) along with a supplement containing creatine and whey protein can help improve strength and well-being in people with cirrhosis who are frail. The goal is to see if this combination can help you feel stronger and more active.
San Francisco, CaliforniaAges 18 years+
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cirrhosis?
- Yes. Clin2 currently lists 261 recruiting cirrhosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cirrhosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cirrhosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.